A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects.
James, Chloé
A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects. [electronic resource] - Trends in molecular medicine Dec 2005 - 546-54 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1471-4914
10.1016/j.molmed.2005.10.003 doi
Gene Components
Humans
Janus Kinase 2
Mutation, Missense--genetics
Myeloproliferative Disorders--genetics
Protein-Tyrosine Kinases--genetics
Proto-Oncogene Proteins--genetics
Receptors, Erythropoietin--metabolism
Signal Transduction--genetics
A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects. [electronic resource] - Trends in molecular medicine Dec 2005 - 546-54 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1471-4914
10.1016/j.molmed.2005.10.003 doi
Gene Components
Humans
Janus Kinase 2
Mutation, Missense--genetics
Myeloproliferative Disorders--genetics
Protein-Tyrosine Kinases--genetics
Proto-Oncogene Proteins--genetics
Receptors, Erythropoietin--metabolism
Signal Transduction--genetics